Investigation of the haemodynamic effects of exenatide in healthy male subjects.
about
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor AgonistsCardiovascular effects of incretin therapy in diabetes care.A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor.Brain GLP-1 and insulin sensitivity.Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.A meta-analysis of the therapeutic effects of glucagon-like Peptide-1 agonist in heart failure.Glucagon-like peptide-1 secretory function as an independent determinant of blood pressure: analysis in the Tanno-Sobetsu study.Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trialEffects of glucagon-like peptide-1 receptor agonists on renal functionDapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetesDifferential effects of glucagon-like peptide-1 receptor agonists on heart rate.GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1Gastrointestinal-Renal Axis: Role in the Regulation of Blood PressureExenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males.Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 studyGlucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathyRenal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy menShort-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
P2860
Q26749495-31FCBFF3-3D8F-448C-ABAE-574ACDF90065Q34171759-92544BDA-DA5C-482D-A002-81ACB324F46CQ35138670-B6BD2DDD-AE94-468A-BC30-7CA9DAC20D89Q35991683-DAC0139D-841D-45FD-B0EC-56A8C1325CFCQ36023385-5B0FB2D4-31AA-4E2E-A233-FE04E04A84C8Q36090588-DCA6A649-C81B-4F42-8539-D51F18778CA9Q36976775-6B1995CF-D4CD-4019-81C6-2B73F2C90968Q36990093-D0E336AE-AB29-40EE-886E-9E4EB9A638B0Q37232679-4AAC7716-7A4D-4452-93F1-0E73822E8381Q37561260-C232ADA4-06C1-4D54-8E14-5572B0C5ED9EQ37586881-79A5914A-5E7E-43B0-9013-1FD84ABDF751Q38055195-FEB7F5BD-5750-4A86-85A3-782EB77646C1Q38177382-AF5F4675-62FD-43B3-AFC9-5EC784B0D3D4Q39164330-7921B42D-E39B-48AE-A699-B547B31F688FQ39220482-64380E68-1494-40E9-8720-9F66ED63D6BEQ41551599-24513A05-B094-4353-A607-16AC49D5E391Q41886690-EF0245CB-5ECF-4C6C-BB1B-45F2F9A207FAQ53215510-618DB902-1D1C-4337-A315-18B71E765808Q53254010-57DE2417-CEC0-4509-974F-231FC866031FQ56967870-4EECC681-48A2-49D7-9035-C3472B72DF40Q58167256-7356F9C8-B092-4787-A941-9F25FAB5BA4EQ58167460-A2C6E49C-F26E-4CD0-9B7B-13D22CEDAEB1Q58447382-58032300-4C5E-4EC7-B6F6-738389C6B218
P2860
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
@ast
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
@en
type
label
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
@ast
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
@en
prefLabel
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
@ast
Investigation of the haemodynamic effects of exenatide in healthy male subjects.
@en
P2860
P1476
Investigation of the haemodynamic effects of exenatide in healthy male subjects
@en
P2093
Buddhike Mendis
Peter Mansell
P2860
P304
P356
10.1111/J.1365-2125.2012.04214.X
P407
P577
2012-09-01T00:00:00Z